Last reviewed · How we verify
NCT05042037
Probiotics as Adjunctive Migraine Prophylaxis
NA trial testing (Microbial cell preparation) probiotics in Migraine in 64 participants. Status unknown.
1 October 2023
Quick facts
| Lead sponsor | Universiti Putra Malaysia |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 64 |
| Start date | 1 October 2022 |
| Primary completion | 1 October 2023 |
| Estimated completion | 1 December 2024 |
| Sites | 1 location across Malaysia |
Drugs / interventions tested
- (Microbial cell preparation) probiotics
- Placebo
Conditions studied
- Migraine — all drugs for Migraine →
- Episodic Migraine — all drugs for Episodic Migraine →
Sponsor
Universiti Putra Malaysia — full company profile →
Who can join
Adults 18 to 60, any sex, with Migraine or Episodic Migraine. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will assess the safety and efficacy of multi-strain probiotics as an adjunctive treatment for episodic migraine
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05042037
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Migraine
Currently open trials in the same condition.
- NCT07419607 — MIGRAFIT: Evaluating a Group Therapy Program Combining Physical Activity, Progressive Muscle Relaxation and Psychoeducat · NA · recruiting
- NCT07487701 — Migraine Prevention With the Remote Electrical Neuromodulation (REN) Wearable: A Real-world Evidence Study · NA · active not recruiting
- NCT07343427 — Impact of GON PRF on Central Sensitization in Migraine Patients · NA · active not recruiting
- NCT07336056 — Nerivio Efficacy Under High-Frequency Use · Phase 4 · active not recruiting
- NCT07385755 — Desvenlafaxine for Preventive Treatment of Frequent Migraines · NA · active not recruiting
Other Universiti Putra Malaysia trials
Trials by the same sponsor.
- NCT07365787 — Internet-Based Group CBT for Anxiety and Depression Among International Students · NA · not yet recruiting
- NCT07325760 — Effectiveness of a ReMIND Diet Intervention on Sarcopenia, Cognitive Frailty and Nutritional Status in Older Adults · NA · not yet recruiting
- NCT07139561 — A Digital Intervention to Improve Oral Health Practices · NA · not yet recruiting
- NCT07095595 — The Effect of Education-based Patient Safety on Nursing Leaders' and Educators' Perceptions of Patient Safety Culture in · NA · active not recruiting
- NCT07115433 — Effectiveness of School-based Oral Health Intervention for Children · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05042037 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universiti Putra Malaysia
- Last refreshed: 3 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05042037.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing